{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:54:42Z","timestamp":1772182482316,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,7]],"date-time":"2010-02-07T00:00:00Z","timestamp":1265500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10549-010-0771-9","type":"journal-article","created":{"date-parts":[[2010,2,6]],"date-time":"2010-02-06T02:09:39Z","timestamp":1265422179000},"page":"281-290","source":"Crossref","is-referenced-by-count":67,"title":["The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature"],"prefix":"10.1007","volume":"123","author":[{"given":"Rebecca","family":"Peare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. T.","family":"Staff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"Heys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,7]]},"reference":[{"key":"771_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181\u2013187","journal-title":"Cancer"},{"key":"771_CR2","first-page":"5565","volume":"48","author":"LLM Shek","year":"1988","unstructured":"Shek LLM, Godolphin W (1988) Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. Cancer Res 48:5565\u20135569","journal-title":"Cancer Res"},{"key":"771_CR3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0959-8049(01)00067-3","volume":"37","author":"JM Ververs","year":"2001","unstructured":"Ververs JM, Roumen RM, Vingerhoets AJ et al (2001) Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37:991\u2013999","journal-title":"Eur J Cancer"},{"key":"771_CR4","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1200\/JCO.2005.03.228","volume":"23","author":"AD Purushotham","year":"2005","unstructured":"Purushotham AD, Upponi S, Klevesath MB et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23:4312\u20134321","journal-title":"J Clin Oncol"},{"key":"771_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1634\/theoncologist.8-1-59","volume":"8","author":"JW Jakub","year":"2003","unstructured":"Jakub JW, Pendas S, Reintgen DS (2003) Current status of sentinel lymph node mapping and biopsy: facts and controversies. Oncologist 8:59\u201368","journal-title":"Oncologist"},{"key":"771_CR6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.sla.0000165200.32722.02","volume":"241","author":"RC Martin II","year":"2005","unstructured":"Martin RC II, Chagpar A, Scoggins CR et al (2005) Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 241:1005\u20131012","journal-title":"Ann Surg"},{"key":"771_CR7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jjco\/hyp019","volume":"39","author":"BJ Chae","year":"2009","unstructured":"Chae BJ, Bae JS, Kang BJ et al (2009) Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer. Jpn J Clin Oncol 39:284\u2013289","journal-title":"Jpn J Clin Oncol"},{"key":"771_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jjco\/hyn120","volume":"39","author":"N Taira","year":"2009","unstructured":"Taira N, Ohsumi S, Takabatake D et al (2009) Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography\/computed tomography fusion imaging. Jpn J Clin Oncol 39:16\u201321","journal-title":"Jpn J Clin Oncol"},{"issue":"29","key":"771_CR9","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1200\/JCO.2008.17.1496","volume":"26","author":"D Fuster","year":"2008","unstructured":"Fuster D, Duch J, Paredes P et al (2008) Preoperative staging of large primary breast cancer with [18F]Fluorodeoxyglucose positron emission tomography\/computed tomography compared with conventional imaging procedures. J Clin Oncol 26(29):4746\u20134751","journal-title":"J Clin Oncol"},{"key":"771_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2407-8-165","volume":"8","author":"S Ueda","year":"2008","unstructured":"Ueda S, Tsuda H, Asakawa H et al (2008) Utility of 18F-fluoro-deoxyglucose emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 8:165","journal-title":"BMC Cancer"},{"key":"771_CR11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-007-9671-z","volume":"109","author":"WT Yang","year":"2008","unstructured":"Yang WT, Le-Petross HT, Macapinlac H et al (2008) Inflammatory breast cancer: PET\/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 109:417\u2013426","journal-title":"Breast Cancer Res Treat"},{"key":"771_CR12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdl425","volume":"18","author":"U Veronesi","year":"2007","unstructured":"Veronesi U, De Cicco C, Galimberti VE et al (2007) A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 18:473\u2013478","journal-title":"Ann Oncol"},{"key":"771_CR13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archsurg.141.8.783","volume":"141","author":"A Chung","year":"2006","unstructured":"Chung A, Liou D, Karlan S et al (2006) Preoperative FDG-PET for axillary metastases in patients with breast cancer. Arch Surg 141:783\u2013788","journal-title":"Arch Surg"},{"key":"771_CR14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/bjs.5338","volume":"93","author":"A Gil-Rendo","year":"2006","unstructured":"Gil-Rendo A, Zornoza G, Garcia-Velloso MJ et al (2006) Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer. Br J Surg 93:707\u2013712","journal-title":"Br J Surg"},{"key":"771_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006231-200603000-00005","volume":"27","author":"R Kumar","year":"2006","unstructured":"Kumar R, Zhuang H, Schnall M et al (2006) FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer. Nucl Med Commun 27:231\u2013236","journal-title":"Nucl Med Commun"},{"key":"771_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1075-122X.2004.21455.x","volume":"10","author":"MK Fehr","year":"2004","unstructured":"Fehr MK, Hornung R, Varga Z et al (2004) Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Breast J 10:89\u201393","journal-title":"Breast J"},{"key":"771_CR17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1245\/ASO.2004.11.033","volume":"11","author":"PJ Lovrics","year":"2004","unstructured":"Lovrics PJ, Chen V, Coates G et al (2004) A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Ann Surg Oncol 11:846\u2013853","journal-title":"Ann Surg Oncol"},{"key":"771_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.2004.04.148","volume":"22","author":"RL Wahl","year":"2004","unstructured":"Wahl RL, Siegel BA, Coleman RE et al (2004) Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol 22:277\u2013285","journal-title":"J Clin Oncol"},{"key":"771_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejso.2003.10.010","volume":"30","author":"G Zornoza","year":"2004","unstructured":"Zornoza G, Garcia-Velloso MJ, Sola J et al (2004) 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer. Eur J Surg Oncol 30:15\u201319","journal-title":"Eur J Surg Oncol"},{"key":"771_CR20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1013828710301","volume":"71","author":"U Guller","year":"2002","unstructured":"Guller U, Nitzsche EU, Schirp U et al (2002) Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!. Breast Cancer Res Treat 71:171\u2013173","journal-title":"Breast Cancer Res Treat"},{"key":"771_CR21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000658-200211000-00012","volume":"236","author":"JJ Hoeven van der","year":"2002","unstructured":"van der Hoeven JJ, Hoekstra OS, Comans EF et al (2002) Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg 236:619\u2013624","journal-title":"Ann Surg"},{"key":"771_CR22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/93.8.630","volume":"93","author":"M Greco","year":"2001","unstructured":"Greco M, Crippa F, Agresti R et al (2001) Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst 93:630\u2013635","journal-title":"J Natl Cancer Inst"},{"key":"771_CR23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002590000448","volume":"28","author":"H Schirrmeister","year":"2001","unstructured":"Schirrmeister H, Kuhn T, Guhlmann A et al (2001) Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 28:351\u2013358","journal-title":"Eur J Nucl Med"},{"key":"771_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02967197","volume":"7","author":"M Ohta","year":"2000","unstructured":"Ohta M, Tokuda Y, Saitoh Y et al (2000) Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer. Breast Cancer 7:99\u2013103","journal-title":"Breast Cancer"},{"key":"771_CR25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00004728-200003000-00017","volume":"24","author":"K Yutani","year":"2000","unstructured":"Yutani K, Shiba E, Kusuoka H et al (2000) Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis. J Comput Assist Tomogr 24:274\u2013280","journal-title":"J Comput Assist Tomogr"},{"key":"771_CR26","first-page":"1003","volume":"40","author":"K Yutani","year":"1999","unstructured":"Yutani K, Tatsumi M, Shiba E et al (1999) Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis. J Nucl Med 40:1003\u20131008","journal-title":"J Nucl Med"},{"key":"771_CR27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00000658-199808000-00012","volume":"228","author":"IC Smith","year":"1998","unstructured":"Smith IC, Ogston KN, Whitford P et al (1998) Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg 228:220\u2013227","journal-title":"Ann Surg"},{"key":"771_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1148\/radiology.203.2.9114082","volume":"203","author":"LP Adler","year":"1997","unstructured":"Adler LP, Faulhaber PF, Schnur KC et al (1997) Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 203:323\u2013327","journal-title":"Radiology"},{"key":"771_CR29","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/88.17.1204","volume":"88","author":"N Avril","year":"1996","unstructured":"Avril N, Dose J, Janicke F et al (1996) Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst 88:1204\u20131209","journal-title":"J Natl Cancer Inst"},{"key":"771_CR30","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/BF01249621","volume":"23","author":"CI Utech","year":"1996","unstructured":"Utech CI, Young CS, Winter PF (1996) Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med 23:1588\u20131593","journal-title":"Eur J Nucl Med"},{"key":"771_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02303557","volume":"1","author":"JP Crowe Jr","year":"1994","unstructured":"Crowe JP Jr, Adler LP, Shenk RR et al (1994) Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings. Ann Surg Oncol 1:132\u2013140","journal-title":"Ann Surg Oncol"},{"key":"771_CR32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1259\/bjr.75.891.750220","volume":"75","author":"AD Murray","year":"2002","unstructured":"Murray AD, Staff RT, Redpath TW et al (2002) Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. Br J Radiol 75:220\u2013228","journal-title":"Br J Radiol"},{"key":"771_CR33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2214\/ajr.176.4.1761069","volume":"176","author":"T Uematsu","year":"2001","unstructured":"Uematsu T, Sano M, Homma K (2001) In vitro high-resolution helical CT of small axillary lymph nodes in patients with breast cancer: correlation of CT and histology. Am J Roentgenol 176:1069\u20131074","journal-title":"Am J Roentgenol"},{"key":"771_CR34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004728-199105000-00017","volume":"15","author":"DE March","year":"1991","unstructured":"March DE, Wechsler RJ, Kurtz AB et al (1991) CT-pathologic correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr 15:440\u2013444","journal-title":"J Comput Assist Tomogr"},{"key":"771_CR35","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/sim.3631","volume":"28","author":"FM Chappell","year":"2009","unstructured":"Chappell FM, Raab GM, Wardlaw JM (2009) When are summary ROC curves appropriate for diagnostic meta-analyses? Stat Med 28:2653\u20132668","journal-title":"Stat Med"},{"key":"771_CR36","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2967\/jnumed.108.052050","volume":"49","author":"TA Heusner","year":"2008","unstructured":"Heusner TA, Kuemmel S, Umutlu L et al (2008) Breast cancer staging in a single session: whole-body PET\/CT mammography. J Nucl Med 49:1215\u20131222","journal-title":"J Nucl Med"},{"key":"771_CR37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/030089169708300211","volume":"83","author":"F Crippa","year":"1997","unstructured":"Crippa F, Agresti R, Donne VD et al (1997) The contribution of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in the preoperative detection of axillary metastases of breast cancer: the experience of the National Cancer Institute of Milan. Tumori 83:542\u2013543","journal-title":"Tumori"},{"key":"771_CR38","first-page":"1398","volume":"35","author":"TR DeGrado","year":"1994","unstructured":"DeGrado TR, Turkington TG, Williams JJ et al (1994) Performance characteristics of a whole-body PET scanner. J Nucl Med 35:1398\u20131406","journal-title":"J Nucl Med"},{"key":"771_CR39","first-page":"1734","volume":"45","author":"O Mawlawi","year":"2004","unstructured":"Mawlawi O, Podoloff DA, Kohlmyer S et al (2004) Performance characteristics of a newly developed PET\/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med 45:1734\u20131742","journal-title":"J Nucl Med"},{"key":"771_CR40","first-page":"1040","volume":"45","author":"S Surti","year":"2004","unstructured":"Surti S, Karp JS (2004) Imaging characteristics of a 3-dimensional GSO whole-body PET camera. J Nucl Med 45:1040\u20131049","journal-title":"J Nucl Med"},{"key":"771_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2288-6-31","volume":"6","author":"J Zamora","year":"2006","unstructured":"Zamora J, Abraira V, Muriel A et al (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31","journal-title":"BMC Med Res Methodol"},{"key":"771_CR42","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/sim.1099","volume":"21","author":"S Walter","year":"2002","unstructured":"Walter S (2002) Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21:1237\u20131256","journal-title":"Stat Med"},{"key":"771_CR43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF00834522","volume":"23","author":"K Scheidhauer","year":"1996","unstructured":"Scheidhauer K, Scharl A, Pietrzyk U et al (1996) Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability. Eur J Nucl Med 23:618\u2013623","journal-title":"Eur J Nucl Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0771-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-0771-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0771-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:32:27Z","timestamp":1559219547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-0771-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-0771-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,7]]}}}